(secondQuint)Trial of Telmisartan 80 mg/HCTZ 12.

5 mg and Telmisartan 40 mg/HCTZ 12.

5 mg in Patients With Hypertension.

 This is a multi-centre study with three centres participating with a target of 30 to 90 patients entering the maintenance period and 20-60 patients completing long-term treatment per centre.

 The recruitment period will be about three months from the start of the study.

 Study Hypothesis: The primary objective of this study is to demonstrate the long-term safety of a fixed dose combination of telmisartan/HCTZ fixed-dose combination treatment.

 This study has no control group; therefore, no hypothesis testing will be performed.

 Comparison(s): This study has no control group.

.

 Trial of Telmisartan 80 mg/HCTZ 12.

5 mg and Telmisartan 40 mg/HCTZ 12.

5 mg in Patients With Hypertension@highlight

The objective of this trial is to assess the safety and efficacy of 52 weeks of open-label treatment with the fixed dose combination of telmisartan 80 mg plus HCTZ 12.

5 mg and telmisartan 40 mg plus HCTZ 12.

5 mg in patients with essential hypertension.

